Yuriy Gankin

Co-founder and Chief Scientific Officer @Quantori

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2020 — Present

Co-founder and Chief Scientific Officer @Quantori

View department →

Cambridge, MA, US

Quantori is at the forefront of transforming drug discovery with a unique value proposition that combines deep scientific domain knowledge with data science and advanced analytics expertise, and software engineering excellence. Our mission is to help biopharma companies speed up discovery of viable drug candidates to deliver new therapies to patients worldwide and optimize treatments for precision healthcare.

EDUCATION

1983 — 1989

Saint Petersburg State Institute of Technology (Technical University)

MS, Chemistry

2019 — 2020

MIT Sloan School of Management

MBA, Business Administration and Management, General

1991 — 1996

Tufts University

Ph.D., Analytical Chemistry

ABOUT YURIY GANKIN

Yuriy Gankin, Ph.D, is a life science researcher, serial entrepreneur, and inventor who has over two decades of expertise in helping life sciences, biotech and pharma companies develop IT solutions for accelerating the discovery and development of novel therapies which treat disease and improve the quality of patient lives.He currently serves as Principal and Chief Scientific and Strategy Officer at Quantori, a developer of intelligent IT and data science solutions for life sciences, pharma, and healthcare organizations. Quantori is at the forefront of transforming drug discovery and healthcare with a unique value proposition that combines advanced analytics, scientific knowledge management, and software engineering excellence.Previously, Dr. Gankin was Chief Life Sciences Officer and Vice President of the Life Sciences Business Unit at EPAM, following the acquisition of GGA Software Services by EPAM. As the cofounder of GGA, he helped build the company into a leading provider of scientific software engineering, algorithm development, and data curation services.Dr. Gankin\'s research has been published in multiple scientific journals and he holds several patents for targeted cancer therapy. His expertise spans research, database development, and modeling in chemistry and biology. Dr. Gankin holds a Ph.D. in Analytical Chemistry from Tufts University where he is a Visiting Scientist, in addition to an MBA from MIT Sloan.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.